Exact Mass: 293.05218940000003

Exact Mass Matches: 293.05218940000003

Found 44 metabolites which its exact mass value is equals to given mass value 293.05218940000003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

[(2R,3S,4R,5R)-3,4-dihydroxy-5-pyrimidin-1-ium-1-yl-tetrahydrofuran-2-yl]methyl dihydrogen phosphate

C9H14N2O7P+ (293.0538604)

Lumiracoxib

2-{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid

C15H13ClFNO2 (293.06188000000003)

Lumiracoxib is a COX-2 selective inhibitor non-steroidal anti-inflammatory drug. On August 11, 2007, Australias Therapeutic Goods Administration (TGA, the Australian equivalent of the FDA) cancelled the registration of lumiracoxib in Australia due to concerns that it may cause liver failure. New Zealand and Canada have also followed suit in recalling the drug. M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents

N-(2-hydroxymethyl-3-chloro-4-hydroxyphenyl)anthranilic acid

2-{[3-chloro-4-hydroxy-2-(hydroxymethyl)phenyl]amino}benzoic acid

C14H12ClNO4 (293.0454822)

N-(2-hydroxymethyl-3-chloro-4-hydroxyphenyl)anthranilic acid belongs to the family of Aminobenzoic Acid Derivatives. These are organic compounds containing a benzoic acid moiety with an amine group attached to the benzene ring.

Lumiracoxib

2-{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid

C15H13ClFNO2 (293.06188000000003)

M - Musculo-skeletal system > M01 - Antiinflammatory and antirheumatic products > M01A - Antiinflammatory and antirheumatic products, non-steroids > M01AH - Coxibs D018501 - Antirheumatic Agents > D000894 - Anti-Inflammatory Agents, Non-Steroidal > D016861 - Cyclooxygenase Inhibitors D004791 - Enzyme Inhibitors > D016861 - Cyclooxygenase Inhibitors > D052246 - Cyclooxygenase 2 Inhibitors C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics C471 - Enzyme Inhibitor > C1323 - Cyclooxygenase Inhibitor D000893 - Anti-Inflammatory Agents

methyl 4-(4-chlorophenyl)imino-5,5,5-trifluoropentanoate

C12H11ClF3NO2 (293.0430372)

8,9-difluoro-5-methyl-1,7-dioxo-6,7-dihydro-1h,5h-pyrido[3,2,1-ij]quinoline-2-carboxylic acid

C14H9F2NO4 (293.0499618)

10-METHYLACRIDINIUM PERCHLORATE

C14H12ClNO4 (293.0454822)

2-(2-bromophenyl)-5-tert-butylpyrazol-3-amine

C13H16BrN3 (293.0527516)

ethyl 2-[2-(4-fluorophenyl)-2-oxoethyl]-1,3-thiazole-4-carboxylate

C14H12FNO3S (293.05218940000003)

4-Anilino-3-nitrobenzenesulfonamide

C12H11N3O4S (293.04702460000004)

Meclofenoxate hydrochloride

Centrophenoxine hydrochloride

C12H17Cl2NO3 (293.05854320000003)

D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D002491 - Central Nervous System Agents > D018697 - Nootropic Agents D020011 - Protective Agents Meclofenoxate hydrochloride is an ester synthesized from DMAE and pCPA, which has the activity of stimulating memory and improving cognition.